Boehringer Ingelheim Pharma Reports Findings in Psoriasis (Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1)

Media coverage

• Title	Boehringer Ingelheim Pharma Reports Findings in Psoriasis (Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1)
  Media name/outlet	Daily Veterinary News
  Country/Territory	United States
  Date	20/08/24
  Persons	Mark Lebwohl